{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:10:43Z","timestamp":1790727043450,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/jcp.0b013e31822bb378","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:58:34Z","timestamp":1317743914000},"page":"593-596","source":"Crossref","is-referenced-by-count":52,"title":["Importance of Gabapentin Dose in Treatment of Opioid Withdrawal"],"prefix":"10.1097","volume":"31","author":[{"given":"Mehrdad","family":"Salehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholam Reza","family":"Kheirabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Maracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Ranjkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1358\/dot.2004.40.7.850478","article-title":"Anticonvulsant drugs in the treatment of substance withdrawal.","volume":"40","author":"Zullino","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1360-0443.2008.02248.x","article-title":"Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients.","volume":"103","author":"Kheirabadi","year":"2008","journal-title":"Addiction"},{"key":"R6-9-20210128","first-page":"636","article-title":"Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum.","volume":"43","author":"Gotz","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(95)00028-9","article-title":"Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA.","volume":"22","author":"Goldlust","year":"1995","journal-title":"Epilepsy Res"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0006-2952(61)90329-X","article-title":"Possible role of enzyme inhibition and repression in drug tolerance and addiction.","volume":"8","author":"Goldstein","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin.","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4088\/JCP.v65n0114","article-title":"Gabapentin reduces cocaine use among addicts from a community clinic sample.","volume":"65","author":"Raby","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.v62n0105","article-title":"Gabapentin in the treatment of cocaine dependence: a case series.","volume":"62","author":"Myrick","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pnpbp.2003.11.020","article-title":"Add-on gabapentin in the treatment of opiate withdrawal.","volume":"28","author":"Martinez-Raga","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-979203","article-title":"Treatment of alcohol withdrawal syndrome with gabapentin.","volume":"32","author":"Bonnet","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0278-5846(01)00234-2","article-title":"Treatment of alcohol withdrawal with gabapentin.","volume":"26","author":"Bozikas","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomized placebo-controlled trial of gabapentin for cocaine dependence.","volume":"81","author":"Bisaga","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01.jcp.0000088905.24613.ad","article-title":"Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial.","volume":"23","author":"Bonnet","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1440-1819.2003.01161.x","article-title":"Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients.","volume":"57","author":"Karam-Hage","year":"2003","journal-title":"Psychiatry Clin Neurosci"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neucli.2004.02.002","article-title":"Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)-correlation with neurophysiological parameters.","volume":"34","author":"Freye","year":"2004","journal-title":"Neurophysiol Clin"},{"key":"R20-9-20210128","first-page":"141","article-title":"On the role of glutamate within the locus ceruleus during the development of opioid dependence and on the expression of withdrawal from dependence on opioids.","volume":"20","author":"Tokuyama","year":"2000","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0701320","article-title":"Gabapentin (neurontin) and S(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.","volume":"121","author":"Field","year":"1997","journal-title":"Br J Pharmacol"},{"key":"R22-9-20210128","first-page":"203","article-title":"Mechanism of action of gabapentin.","volume":"7","author":"Brown","year":"1996","journal-title":"Rev Contemp Pharmacother"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0003-9993(97)90020-4","article-title":"Reflex sympathetic dystrophy treated with gabapentin.","volume":"78","author":"Mellik","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00002508-199603000-00010","article-title":"Gabapentin adjunctive therapy in neuropathic pain states.","volume":"12","author":"Rosner","year":"1996","journal-title":"Clin J Pain"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201110000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:04Z","timestamp":1786048024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201110000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31822bb378","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}